The diabetes clinical trials is experiencing robust growth driven by the increasing global burden of the disease, which is projected to affect over 853 million people by 2050. This dramatic rise is attributed to an aging global population, sedentary lifestyles, increasing rates of childhood and ad...Read More »
August 5, 2025
The U.S. independent freestanding emergency department market was valued at USD 1,458.71 million in 2024 and is expected to reach USD 1,985.64 million by 2030 at a CAGR of 5.28% from 2025 to 2030. The study covers independent freestanding emergency departments at state & county level which hel...Read More »
August 4, 2025
The global healthcare staffing & scheduling market was valued at USD 2.53 billion in 2024 and is expected to grow at a CAGR of 13.49% from 2025 to 2030 to reach USD 5.36 billion by 2030. The market is witnessing significant growth, fueled by increasing operational complexity, persistent workfo...Read More »
July 30, 2025
As healthcare continues to evolve, companies are developing new methods to ensure the highest level of sterilization for medical instruments. Advancements in technology are expanding what's possible, allowing for more efficient, reliable, and innovative solutions to meet the growing demands of ste...Read More »
July 28, 2025
The clinical trials in mental health is being driven by the escalating global burden of psychiatric disorders and the urgent unmet need for innovative treatment options across depression, anxiety, PTSD, schizophrenia, and bipolar disorder. Increasing prevalence of these conditions, paired with gro...Read More »
July 21, 2025
The nutritional supplements industry is experiencing a major evolution as consumers shift from standardized health solutions toward highly personalized regimens. Fueled by advances in health diagnostics, wearable tech, and AI, a growing number of consumers now seek supplements tailored to their un...Read More »
July 8, 2025
The global biomanufacturing sector is undergoing a strategic transformation driven by increased demand for biologics, evolving therapeutic modalities, and growing emphasis on regionalized manufacturing. This trend report provides an in-depth analysis of the biomanufacturing landscape, focusing on ...Read More »
July 7, 2025
The dietary supplements market in the U.S. is undergoing a transformation as consumers shift their focus from reactive to preventive healthcare. Driven by heightened health consciousness, lifestyle-related disorders, and growing interest in wellness, supplements are no longer just a niche category...Read More »
July 4, 2025
The neurology clinical trials landscape is witnessing rapid growth, driven by increasing burden of central nervous system (CNS) disorders, Alzheimer's, Parkinson's, and epilepsy, a rising trend toward outsourcing, and a growing volume of clinical and decentralized trials. Advancements in technolog...Read More »
July 2, 2025
Oncology codes (Z5112, Z5111) drive nearly 25%+ of total payment-2-3x above national avg. charges; musculoskeletal procedures (M1711) show high charges with modest payments
...Read More »July 2, 2025
Omics technologies encompassing genomics, proteomics, metabolomics, transcriptomics, and epigenomics have transformed clinical trials by enabling a deeper understanding of biological variability among patients. These approaches allow researchers to identify molecular biomarkers that predict drug r...Read More »
June 30, 2025
Dr. Jonathan Dario leads in both volume and case complexity, pointing to his role in driving high-acuity care and influencing hospital resource distribution.
...Read More »June 30, 2025
Autologous cell therapy represents a groundbreaking shift in modern medicine. While engineered T cell therapies have made major strides in immuno-oncology, the global market is now growing to include other therapeutic areas such as autoimmune diseases and transplant rejection. A critical factor in...Read More »
June 30, 2025
The cell & gene therapy clinical trials landscape is witnessing rapid growth, driven by increasing genetic and rare diseases, accelerating regulatory pathways, rising venture capital investment,growing demand for outsourced cell & gene therapy services & rising advancements in gene edi...Read More »
June 27, 2025
Neonatal ICU and ICU have the highest cost per day and cost-to-charge ratios, suggesting higher intensity care but lower charge recovery efficiency compared to General Med/Surg.
...Read More »June 26, 2025
The Asia Pacific dietary supplements market is witnessing rapid transformation, driven by a growing middle class, increasing health awareness, and a deepening focus on preventive care and immunity. APAC is one of the fastest-growing regions globally, fueled by rising demand for vitamins, minerals,...Read More »
June 25, 2025
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the life science outsourcing space and have seen the evolution of these players from just a handful to now over 200 co...Read More »
June 25, 2025
Technological advancements have become a significant catalyst in redesigning the landscape of clinical trials, primarily enhancing trial efficiency, patient engagement, data accuracy, and overall trial outcomes. Innovations such as Decentralized Clinical Trials (DCTs), Artificial Intelligence (AI)...Read More »
June 24, 2025
The EMEA market continues to grow steadily, fueled by aging populations, rising healthcare awareness, and a strong cultural orientation toward preventive and integrative health practices. Consumers across the region are increasingly turning to vitamins, minerals, probiotics, plant-based extracts, ...Read More »
June 24, 2025
The Southeast Asia (SEA) dietary supplements market is witnessing robust and sustained growth, driven by a confluence of socioeconomic and health-related factors. One of the primary catalysts is the growing health consciousness among consumers, who are increasingly prioritizing preventive healthca...Read More »
June 24, 2025